Literature DB >> 25913637

Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring.

Bahram Mohammadi1,2, Katja Kollewe3, David M Cole4, Anja Fellbrich1, Marcus Heldmann1, Amir Samii2, Reinhard Dengler3, Susanne Petri3, Thomas F Münte1,5, Ulrike M Krämer1,5.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by muscular atrophy, spasticity, and bulbar signs caused by loss of upper and lower motor neurons. Evidence suggests that ALS additionally affects other brain areas including premotor cortex and supplementary motor area. Here, we studied movement execution and inhibition in ALS patients using a stop-signal paradigm and functional magnetic resonance imaging. Seventeen ALS patients and 17 age-matched healthy controls performed a stop-signal task that required responding with a button press to a right- or left-pointing black arrow (go-stimuli). In stop-trials, a red arrow (stop-stimulus) was presented shortly after the black arrow indicating to withhold the prepared movement. Patients had by trend higher reaction times in go-trials but did not differ significantly in their inhibition performance. Patients showed stronger inhibition-related activity in inferior, superior, and middle frontal gyri as well as in putamen and pallidum. Error-related activity, conversely, was found to be stronger in healthy controls, particularly in the insula bilaterally. Patients also showed increased activity in the motor cortex during button presses. The results provide evidence for altered prefrontal and subcortical networks underlying motor execution, motor inhibition, and error monitoring in ALS.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ALS; error monitoring; fMRI; prefrontal cortex; stop-signal task

Mesh:

Year:  2015        PMID: 25913637      PMCID: PMC6869134          DOI: 10.1002/hbm.22814

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  43 in total

1.  The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis.

Authors:  A Miyake; N P Friedman; M J Emerson; A H Witzki; A Howerter; T D Wager
Journal:  Cogn Psychol       Date:  2000-08       Impact factor: 3.468

2.  Complex cognitive disruption in motor neuron disease.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Nicola Carraro; Giuseppe Cazzato; Antonio Bava
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Mechanisms and dynamics of cortical motor inhibition in the stop-signal paradigm: a TMS study.

Authors:  Wery P M van den Wildenberg; Borís Burle; Franck Vidal; Maurits W van der Molen; K Richard Ridderinkhof; Thierry Hasbroucq
Journal:  J Cogn Neurosci       Date:  2010-02       Impact factor: 3.225

5.  Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation.

Authors:  U Ziemann; M Winter; C D Reimers; K Reimers; F Tergau; W Paulus
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

6.  Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study.

Authors:  Carsten Konrad; Henning Henningsen; Janbernd Bremer; Brian Mock; Michael Deppe; Christiane Buchinger; Pat Turski; Stefan Knecht; Benjamin Brooks
Journal:  Exp Brain Res       Date:  2002-01-24       Impact factor: 1.972

7.  Structural and functional evaluation of cortical motor areas in Amyotrophic Lateral Sclerosis.

Authors:  Mirco Cosottini; Ilaria Pesaresi; Selina Piazza; Stefano Diciotti; Paolo Cecchi; Serena Fabbri; Cecilia Carlesi; Mario Mascalchi; Gabriele Siciliano
Journal:  Exp Neurol       Date:  2011-12-27       Impact factor: 5.330

8.  Comparison between impairment and disability scales in immune-mediated polyneuropathies.

Authors:  Ingemar S J Merkies; Paul I M Schmitz; Frans G A Van Der Meché; Pieter A Van Doorn
Journal:  Muscle Nerve       Date:  2003-07       Impact factor: 3.217

9.  Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI.

Authors:  Adam R Aron; Tim E Behrens; Steve Smith; Michael J Frank; Russell A Poldrack
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

10.  The cortical signature of amyotrophic lateral sclerosis.

Authors:  Federica Agosta; Paola Valsasina; Nilo Riva; Massimiliano Copetti; Maria Josè Messina; Alessandro Prelle; Giancarlo Comi; Massimo Filippi
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more
  13 in total

1.  Disrupted effective connectivity of the sensorimotor network in amyotrophic lateral sclerosis.

Authors:  Xiaojing Fang; Yuanchao Zhang; Yue Wang; Yuling Zhang; Jun Hu; Jian Wang; Jiuquan Zhang; Tianzi Jiang
Journal:  J Neurol       Date:  2016-01-07       Impact factor: 4.849

2.  Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis.

Authors:  Malcolm Proudfoot; Gustavo Rohenkohl; Andrew Quinn; Giles L Colclough; Joanne Wuu; Kevin Talbot; Mark W Woolrich; Michael Benatar; Anna C Nobre; Martin R Turner
Journal:  Hum Brain Mapp       Date:  2016-09-13       Impact factor: 5.038

3.  Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis.

Authors:  Weina Li; Jiuquan Zhang; Chaoyang Zhou; Wensheng Hou; Jun Hu; Hua Feng; Xiaolin Zheng
Journal:  Front Aging Neurosci       Date:  2018-07-17       Impact factor: 5.750

Review 4.  Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis.

Authors:  Miguel Mazón; Juan Francisco Vázquez Costa; Amadeo Ten-Esteve; Luis Martí-Bonmatí
Journal:  Front Neurosci       Date:  2018-10-25       Impact factor: 4.677

Review 5.  Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis.

Authors:  Foteini Christidi; Efstratios Karavasilis; Michail Rentzos; Nikolaos Kelekis; Ioannis Evdokimidis; Peter Bede
Journal:  Front Neurol       Date:  2018-11-22       Impact factor: 4.003

Review 6.  Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis.

Authors:  Malcolm Proudfoot; Peter Bede; Martin R Turner
Journal:  Front Neurol       Date:  2019-01-08       Impact factor: 4.003

7.  Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis.

Authors:  Smriti Agarwal; Elizabeth Highton-Williamson; Jashelle Caga; James Howells; Thanuja Dharmadasa; José M Matamala; Yan Ma; Kazumoto Shibuya; John R Hodges; Rebekah M Ahmed; Steve Vucic; Matthew C Kiernan
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.996

8.  Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Caroline Seer; Stefanie Fürkötter; Maj-Britt Vogts; Florian Lange; Susanne Abdulla; Reinhard Dengler; Susanne Petri; Bruno Kopp
Journal:  Front Aging Neurosci       Date:  2015-12-18       Impact factor: 5.750

9.  A Systematic Review and Meta-Analysis of the Functional MRI Investigation of Motor Neuron Disease.

Authors:  Dongchao Shen; Liying Cui; Bo Cui; Jia Fang; Dawei Li; Junfang Ma
Journal:  Front Neurol       Date:  2015-11-24       Impact factor: 4.003

Review 10.  The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.

Authors:  G Grolez; C Moreau; V Danel-Brunaud; C Delmaire; R Lopes; P F Pradat; M M El Mendili; L Defebvre; D Devos
Journal:  BMC Neurol       Date:  2016-08-27       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.